Use and Disclosure of the Information Clause Samples

The 'Use and Disclosure of the Information' clause defines how parties may utilize and share information exchanged under an agreement. Typically, it outlines the permitted purposes for which the information can be used, such as fulfilling contractual obligations, and sets boundaries on when and with whom the information may be disclosed, often restricting disclosure to authorized personnel or third parties under similar confidentiality obligations. This clause serves to protect sensitive or proprietary information by ensuring it is not misused or improperly shared, thereby mitigating the risk of unauthorized disclosure.
Use and Disclosure of the Information. The Receiving Party shall keep the Confidential Information and any document created by using the Confidential Information secure and protected from any use from anyone, including but not limited to from any disclosure, copy, reproduction, or access. The Receiving Party shall treat the Confidential Information in the Agreement in a similar manner with the treatment it confer upon its own trade secret and other confidential information, particularly regarding safeguard measure accorded upon such Confidential Information.
View SourceView Similar (3)
Use and Disclosure of the Information. (a) The MyHT Members agree that the Primary Care EMR Data Extracts will be used and disclosed by Manitoba for the additional purposes identified below: (i) to generate MyHT performance indicator reports for the MyHT Members to support continuous quality improvement activities within the MyHT; (ii) to evaluate performance of the overall provincial MyHT initiative, and progress towards achievement of provincial goals; (b) The MyHT Members acknowledge and agree that, in support of the purposes identified, Manitoba will disclose performance indicator information with the other MyHT Members. This information will be in aggregate form and will not be identifiable Personal Health Information, but may be identifiable at the clinic or organization level. Similarly, aggregate information may be shared across MyHTs to enable analysis in support of the overall provincial MyHT initiative. (c) The MyHT Members will disclose the information to Manitoba through Manitoba’s information manager, Manitoba eHealth, unless other disclosure methods are arranged and approved.
View SourceView Similar (2)

Related to Use and Disclosure of the Information

  • Use and Disclosure of PHI Business Associate is limited to the following permitted and required uses or disclosures of PHI: a. Duty to Protect PHI. Business Associate shall protect PHI from, and shall use appropriate safeguards, and comply with Subpart C of 45 CFR Part 164 (Security Standards for the Protection of Electronic Protected Health Information) with respect to EPHI, to prevent the unauthorized Use or disclosure of PHI other than as provided for in this Contract or as required by law, for as long as the PHI is within its possession and control, even after the termination or expiration of this Contract.

  • Use and Disclosure of Confidential Information Notwithstanding anything to the contrary contained in this Agreement, and in addition to and not in lieu of other provisions in this Agreement:

  • Permitted Uses and Disclosures i. Business Associate shall use and disclose PHI only to accomplish Business Associate’s obligations under the Contract. i. To the extent Business Associate carries out one or more of Covered Entity’s obligations under Subpart E of 45 C.F.R. Part 164, Business Associate shall comply with any and all requirements of Subpart E that apply to Covered Entity in the performance of such obligation. ii. Business Associate may disclose PHI to carry out the legal responsibilities of Business Associate, provided, that the disclosure is Required by Law or Business Associate obtains reasonable assurances from the person to whom the information is disclosed that: A. the information will remain confidential and will be used or disclosed only as Required by Law or for the purpose for which Business Associate originally disclosed the information to that person, and; B. the person notifies Business Associate of any Breach involving PHI of which it is aware. iii. Business Associate may provide Data Aggregation services relating to the Health Care Operations of Covered Entity. Business Associate may de-identify any or all PHI created or received by Business Associate under this Agreement, provided the de-identification conforms to the requirements of the HIPAA Rules.

  • Permitted Use and Disclosures Each Party hereto may use or disclose Confidential Information disclosed to it by the other Party to the extent such information is included in the Pharmacopeia Technology, Schering Technology or Collaboration Technology, as the case may be, and to the extent (i) such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder in filing or prosecuting patent applications, prosecuting or defending litigation, (ii) such disclosure is reasonably required to be made to any institutional review board of any entity conducting clinical trials with Agreement Compound(s) and/or Agreement Product(s), or to any governmental or other regulatory agency, in order to gain approval to conduct clinical trials or to market Agreement Compound(s) and/or Agreement Products, (iii) such disclosure is required by law, regulation, rule, act or order of any governmental authority, court, or agency, or is made in connection with submitting required information to tax or other governmental authorities, or (iv) such disclosure or use is reasonably required in conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted to it by the other Party pursuant to the terms of this Agreement; in each case, provided that if a Party is required to make any such disclosure of another Party’s Confidential Information, other than pursuant to a confidentiality agreement, it will give reasonable advance notice to the other Party of such disclosure and, save to the extent inappropriate in the case of patent applications, will use its reasonable diligent efforts to secure confidential treatment of such Confidential Information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

  • Use and Disclosure of Protected Health Information The Business Associate must not use or further disclose protected health information other than as permitted or required by the Contract or as required by law. The Business Associate must not use or further disclose protected health information in a manner that would violate the requirements of HIPAA Regulations.